![C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001](https://i0.wp.com/rt.prnewswire.com/rt.gif?NewsItemId=CN95786&Transmission_Id=202510110845PR_NEWS_USPR_____CN95786&DateId=20251011&w=200&resize=200,70&ssl=1 "C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001")
CHENGDU, China, Oct. 11, 2025 /PRNewswire/ — C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the National Medical Products Administration (NMPA) for the clinical trial application of […]
CHENGDU, China, Oct. 11, 2025 /PRNewswire/ — C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the National Medical Products Administration (NMPA) for the clinical trial application of […]
